The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Natural Gene-Expression Variation in Down Syndrome Modulates the Outcome of Gene-Dosage Imbalance
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
More powerful procedures for multiple significance testing
Hochberg, Y., & Benjamini, Y. (1990) · Statistics in Medicine · doi:10.1002/sim.4780090710 · Cited by 2,715 · cited 4×
“The significance threshold was set at .01 after correction for multiple testing by use of the Benjamini-Hochberg FDR.24 The average up-regulation ratio (DS:euploid) was 1.44 in LCLs and 1.67 in fibroblasts; these values are similar to the expected up-regulation of gene expression of 1.5-fold in trisomy 21 (fig.1B and…”
MethodInfluentialVariation in gene expression within and among natural populations
Oleksiak, M. F., Churchill, G. A., & Crawford, D. L. (2002) · Nature Genetics · doi:10.1038/ng983 · Cited by 736 · cited 1×
“Several recent studies, mainly using LCLs and array-based transcriptome analyses, concluded that there is substantial gene-expression variation in unaffected individuals.(7,29,30) In addition, a considerable fraction of this normal gene-expression variation is genetically determined.”
ResultChromosome 21 and Down syndrome: from genomics to pathophysiology
Antonarakis, S. E., Lyle, R., Dermitzakis, E. T., Reymond, A., & Deutsch, S. (2004) · Nature Reviews Genetics · doi:10.1038/nrg1448 · Cited by 703 · cited 2×
“Thus, a likely molecular mechanism for the variability of phenotypic manifestations of trisomy 21 is a threshold effect of expression of HSA21 genes that show variable levels of expression in the population.(20) In this study, we have looked at HSA21 gene overexpression in trisomy 21 in the context of natural geneexpr…”
BackgroundSelf-citationKahlem, P., Sultan, M., Herwig, R., Steinfath, M., Balzereit, D., Eppens, B., Saran, N. G., Pletcher, M. T., South, S. T., Stetten, G., et al. (2004) · Genome Research · doi:10.1101/gr.1951304 · Cited by 249
Primary and secondary transcriptional effects in the developing human down syndrome brain and heart
Mao, R., Wang, X., Spitznagel, E. L., Frelin, L. P., Ting, J. C., Ding, H., Kim, J.-W., Ruczinski, I., Downey, T. J., & Pevsner, J. (2005) · Genome Biology · doi:10.1186/gb-2005-6-13-r107 · Cited by 166
Cited by
Gene balance hypothesis: Connecting issues of dosage sensitivity across biological disciplines
Birchler, J. A., & Veitia, R. A. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1207726109 · Cited by 581
“Down syndrome: an insight of the disease”
Asim, A., Kumar, A., Muthuswamy, S., Jain, S., & Agarwal, S. (2015) · Journal of Biomedical Science · doi:10.1186/s12929-015-0138-y · Cited by 371
Translating dosage compensation to trisomy 21
Jiang, J., Jing, Y., Cost, G. J., Chiang, J.-C., Kolpa, H. J., Cotton, A. M., Carone, D. M., Carone, B. R., Shivak, D. A., Guschin, D. Y., et al. (2013) · Nature · doi:10.1038/nature12394 · Cited by 335
Lyle, R., Béna, F., Gagos, S., Gehrig, C., Lopez, G., Schinzel, A., Lespinasse, J., Bottani, A., Dahoun, S., Taine, L., et al. (2009) · European Journal of Human Genetics · doi:10.1038/ejhg.2008.214 · Cited by 331
Self-citationDomains of genome-wide gene expression dysregulation in Down’s syndrome
Letourneau, A., Santoni, F. A., Bonilla, X., Sailani, M. R., Gonzalez, D., Kind, J., Chevalier, C., Thurman, R., Sandstrom, R. S., Hibaoui, Y., et al. (2014) · Nature · doi:10.1038/nature13200 · Cited by 319
Self-citationTranscriptomic and cellular decoding of regional brain vulnerability to neurogenetic disorders
Seidlitz, J., Nadig, A., Liu, S., Bethlehem, R. A. I., Vértes, P. E., Morgan, S. E., Váša, F., Romero-Garcia, R., Lalonde, F. M., Clasen, L. S., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17051-5 · Cited by 318
Down syndrome and the complexity of genome dosage imbalance
Antonarakis, S. E. (2017) · Nature Reviews Genetics · doi:10.1038/nrg.2016.154 · Cited by 299
Self-citationMolecular genetic analysis of Down syndrome
Patterson, D. (2009) · Human Genetics · doi:10.1007/s00439-009-0696-8 · Cited by 278
Ohnologs in the human genome are dosage balanced and frequently associated with disease
Makino, T., & McLysaght, A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914697107 · Cited by 274
Duchon, A., & Herault, Y. (2016) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2016.00104 · Cited by 181
Colacurcio, D. J., Pensalfini, A., Jiang, Y., & Nixon, R. A. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.10.001 · Cited by 167
Systematic proteome and proteostasis profiling in human trisomy 21 fibroblast cells
Liu, Y., Borel, C., Li, L., Müller, T., Williams, E. G., Germain, P.-L., Buljan, M., Sajic, T., Boersema, P. J., Shao, W., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01422-6 · Cited by 141
Self-citationGribble, S. M., Wiseman, F. K., Clayton, S., Prigmore, E., Langley, E., Yang, F., Maguire, S., Fu, B., Rajan, D., Sheppard, O., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060482 · Cited by 102
“The expression levels of HSPA13, SAMSN1, USP25, PRMT2 and S100B are sensitive to gene dosage [20,21].”
BackgroundIntegrated Quantitative Transcriptome Maps of Human Trisomy 21 Tissues and Cells
Pelleri, M. C., Cattani, C., Vitale, L., Antonaros, F., Strippoli, P., Locatelli, C., Cocchi, G., Piovesan, A., & Caracausi, M. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00125 · Cited by 61
Hart, S. J., Visootsak, J., Tamburri, P., Phuong, P., Baumer, N., Hernandez, M., Skotko, B. G., Ochoa‐Lubinoff, C., Liogier D'Ardhuy, X., Kishnani, P. S., et al. (2017) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.38465 · Cited by 54
Ishihara, K. (2021) · Genes · doi:10.3390/genes12101598 · Cited by 8
“In addition, an elevated expression of EURL in the lymphoblastic cells derived from people with DS has been shown [71,72].”
Background
Metadata
- Authors
- Prandini, P., Deutsch, S., Lyle, R., Gagnebin, M., Vivier, C. D., Delorenzi, M., Gehrig, C., Descombes, P., Sherman, S., Bricarelli, F. D., Baldo, C., Novelli, A., Dallapiccola, B., & Antonarakis, S. E.
- Venue
- The American Journal of Human Genetics
- Publisher
- Elsevier BV
- Published
- 2007-08
- Volume
- 81
- Issue
- 2
- Pages
- 252-263
- ISSN
- 0002-9297 (ISSN-L)
- OpenAlex
- W2073248118
- Cited by
- 196
- References
- 5
- FWCI
- 13.45
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.